National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 359436

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 359436
VAERS Form:
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 2 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without patholo
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 4/14/2017

VAERS ID: 359436 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 2 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without patholo pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 9/14/2017

VAERS ID: 359436 Before After
VAERS Form:(blank) 1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 2 3 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 2/14/2018

VAERS ID: 359436 Before After
VAERS Form:1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 3 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 6/14/2018

VAERS ID: 359436 Before After
VAERS Form:1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 3 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 8/14/2018

VAERS ID: 359436 Before After
VAERS Form:1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 3 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.


Changed on 9/14/2018

VAERS ID: 359436 Before After
VAERS Form:1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2004-01-06
Onset:0000-00-00
Submitted:2009-10-05
Entered:2009-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS HAB285A9 / 3 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Ear pain, Fatigue, Fontanelle bulging, Headache, Infection, Lumbar puncture normal, Malaise, Meningism, Nausea, Nephritis, Nuclear magnetic resonance imaging normal, Pyrexia, Toothache, Urine analysis, Ultrasound scan abnormal, Blood test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Lumbar puncture, Sep1991, normal; After vaccination with DTP-HIB-POLIO: Sonogram of the skull was borderline. After vaccination with TWINRIX PEDIATRIC: Several blood and urine examinations; magnetic resonance tomography without pathological findings
CDC 'Split Type': D0063028A

Write-up: This case was reported by a foreign regulatory authority (# DE-PEI-PEI2009020984) and described the occurrence of nephritis in a 5-month-old female subject (born 02 April 1991) who was vaccinated with TWINRIX pediatric (GlaxoSmithKline). Previous vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine given on 03 July 1991 and 31 July 1991 was well tolerated. On 4 September 1991 the subject received 3rd dose of combined Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine (unknown manufacturer, unknown route, probably right thigh). At an unspecified time after vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae the subject experienced fever and bulging fontanelle. Meningism was suspected but not confirmed. Next vaccinations with TWINRIX pediatric given on 06 May 2002 and 17 June 2002 were well tolerated. On 6 January 2004 the subject received 3rd dose of TWINRIX pediatric (unknown route, unknown upper arm). At an unspecified time after vaccination with TWINRIX adult, the subject experienced recurrent nephritis, infection, headache, ear pain, toothache, unclear fatigue and nausea. Ambulatory treatment was necessary. The subject was hospitalised. At the time of reporting the events were resolved. After the next vaccination with Diphtheria + tetanus + pertussis + polio + haemophilus influenzae vaccine these events did not recur. On 30 April 2007, 26 June 2007 and 16 November 2007 the subject received GARDASIL (Sanofi Pasteur MSD, intramuscular, left upper arm). An unspecified time after vaccination the subject experienced felling of illness, headache, nausea and recurrent dyspnoea. No further information has been provided. No further information will be available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=359436&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166